Federico Vozzi

Federico Vozzi is a Researcher at the Istituto di Fisiologia Clinica del CNR in Pisa, where he is the Principal Investigator of the Biomimetic Materials and Biological Tissue Engineering. In 2007 he received a Ph.D. in Drug Science from the University of Pisa.His research focuses on tissue engineering for cardiovascular application, 3D-printing and development and testing of bioreactors, and New Approach Methodologies (NAMs) for chemical risk assessment. He has a strong experience in studies mainly focused on cardiovascular systems where cardiomyocytes/endothelial, smooth muscle cells were studied in their modulation of phenotypic characteristics through the support of tissue engineering systems (scaffolds, bioreactors): a type of approach useful to recreate and mimic the physiological environment. Thanks to the help of advanced molecular biology techniques, a wide spectrum of analytical assays is routinely performed to support the comprehension of physio-pathological mechanisms of cardiac and metabolic diseases.He is the coordinator or unit leader of several projects and the Technical Manager of the H2020 ALTERNATIVE project. Dr. Federico Vozzi is the author and co-author of > 100 scientific papers in international journals with peer review, presentations to national and international conferences, and the author of 3 patents.Federico Vozzi is co-founder of “Kirkstall Ltd”, a UK biotechnology company operating within the global organ-on-a-chip market.